Innovation Pharmaceuticals Inc (IPIX)

[steelyeye]

Citing the letter of the law, not the spirit... so call all the bs you like, but next time include the context of the entire paragraph.

In in vitro studies, Brilacidin was found to be a potent inhibitor of all variants of SARS-CoV-2, from the Washington to the Italian, from the English to the Danish and South African variants. Another interesting fact, which emerged from the preclinical study, is the effectiveness of Brilacidin on other coronaviruses that infect humans, in addition to SARS-CoV-2, such that it can be defined as a "pan-coronavirus" drug.

If Brilacidin pops the viral envelope in this upcoming trial, pan-corona becomes the accurate phrase. As you know, it did just that in the gov. lab.